GlassScriptPhysician profile
Ying Buckley
NPI 1770622888
$24,615.48
in general payments reported to CMS, 2019-2025
7 companies · $956 in 2025
The $956 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,438 · 2022: $2,309 · 2023: $6,845 · 2024: $9,068 · 2025: $956.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Food and Beverage: $3,817 · Travel and Lodging: $1,434 · Education: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,350.00 |
| Food and Beverage | $3,816.81 |
| Travel and Lodging | $1,434.41 |
| Education | $267.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $22,379.73 | 2021-2025 | Uzedy, Austedo Xr, Austedo |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $887.37 | 2021-2025 | Caplyta |
| Alkermes, INC. | $609.44 | 2022-2024 | Aristada, Lybalvi, Aristada Initio |
| Janssen Pharmaceuticals, INC | $282.73 | 2023 | Invega Sustenna |
| Neurocrine Biosciences, INC. | $227.47 | 2022-2023 | Ingrezza |
| E.R. Squibb & Sons, L.L.C. | $124.60 | 2024 | Cobenfy |
| Otsuka America Pharmaceutical, INC. | $104.14 | 2024 | Abilify Asimtufii, Abilify Maintena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ying Buckley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.